Autocatalytic processing of recombinant human procathepsin B is a bimolecular process11Dedicated to Prof. Pavao Mildner on the occasion of his 80th birthday.  by Rozman, Jerica et al.
Autocatalytic processing of recombinant human procathepsin B is a
bimolecular process1
Jerica Rozmana;*, Jure Stojanb, Robert Kuhelja, Vito Turka, Boris Turka
a Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia
b Institute of Biochemistry, Medical Faculty, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
Received 12 July 1999; received in revised form 7 September 1999
Abstract Cathepsin B and other lysosomal cysteine proteinases
are synthesized as inactive zymogens, which are converted to
their mature forms by other proteases or by autocatalytic
processing. Procathepsin B autoactivation was shown in vitro at
pH 4.5 to be a bimolecular process with Ks and kcat values of
2.1 þ 0.9 WM and 0.12 þ 0.02 s31, respectively. Autoactivation is
substantially accelerated in the presence of active cathepsin B
molecules, indicating that mature cathepsin B is the catalytic
species in the process. Proenzyme is cleaved without significant
conformational changes as judged by circular dichroism,
suggesting that propeptide unfolding occurs only after the
cleavage. Procathepsin B autoactivation is pH-dependent with
a pH optimum at 4.5 and with no processing observed at
pHs 6.0. However, in the presence of 0.5 Wg/ml of dextran
sulfate, relatively rapid processing is observed even at pH 6.5
(t1=2V90 min), suggesting that glycosaminoglycans are involved
in in vivo processing of lysosomal cysteine proteases.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Cathepsin B is the most abundant lysosomal cysteine pro-
tease and is involved in a number of cellular processes, includ-
ing protein degradation and turnover [1,2]. The enzyme was
also found extracellularly in some pathological states such as
arthritis [3], Alzheimer’s disease [4], cancer invasion and meta-
stasis [5,6].
Like other related proteases, cathepsin B is synthesized as a
preproenzyme [7]. The prepeptide is removed during the pas-
sage to the endoplasmic reticulum and procathepsin B under-
goes proteolytic processing to active, mature enzyme in late
endosomes or lysosomes [8,9]. Propeptide, which is removed
in the last step, serves several important functions: (i) it reg-
ulates enzymatic activity in vitro by acting as a tight binding
inhibitor of mature cathepsin B [10], (ii) it is responsible for
proper targeting of the enzyme [11] and (iii) it might be im-
portant for the stability and proper folding of the enzyme, as
shown for cathepsin L [12]. In vitro experiments showed that
procathepsin B could be activated by the action of di¡erent
proteinases, such as pepsin and cathepsin D [13], and by au-
tocatalytic processing at acidic pH, which was suggested to be
a unimolecular process [13^15]. Later studies on cathepsins L
and K, however, suggested that the reaction mechanism in-
volves intermolecular as well as intramolecular steps [16,17].
Further evidence that an intramolecular activation mechanism
is highly unlikely came from structural studies on procathep-
sins B, L and K [18^23]. The structure of the catalytic part
was shown to be formed in the proenzyme and the propeptide
was shown to be bound in the active site cleft in the direction
opposite to the normal substrate. This would therefore require
a large movement of the propeptide to bind into the active site
in the proper orientation for cleavage [19].
In this work, we provide unambiguous evidence that pro-
cathepsin B autoprocessing is a bimolecular process, which
can be substantially accelerated in the presence of charged
surfaces. On the basis of these results, a model has been sug-
gested for autoprocessing of cathepsin B and related protein-
ases.
2. Materials and methods
2.1. Materials
Z-Arg-Arg-AMC and Z-Arg-Arg-pNA were purchased from Bach-
em (Bubendorf, Switzerland). Dimethylsulfoxide was obtained from
Merck (Darmstadt, Germany). E-64 was from Peptide Research In-
stitute (Osaka, Japan).
Recombinant human procathepsin B and human cathepsin B were
produced and puri¢ed [24]. In order to produce mutant procathepsin
B (Cys-29-Ser), mutagenesis was performed as described [25]. The
oligonucleotide 5P-GCTCCTCCTGGGCCTT-3P (the altered base is
underlined) was used for the introduction of the Cys-29-Ser substitu-
tion. Refolding and puri¢cation of mutant procathepsin B were car-
ried out as described previously [24].
Protein concentrations were determined by absorbance using a Per-
kin Elmer V-18 spectrophotometer (USA) according to Pace et al. [26].
The concentration of active cathepsin B was determined by active site
titration with E-64 [27].
2.2. Kinetic measurements
All measurements were performed at 37‡C using plastic tubes to
avoid the e¡ect of glass surfaces on the autoprocessing rate of proca-
thepsin B [28]. The processing bu¡er was Tris-HCl pH 7.6, 3 mM
EDTA, 5 mM cysteine and was acidi¢ed to the required pH with
1 M Na-acetate pH 4.0. When not speci¢ed, kinetics of cathepsin B
autoprocessing were studied at pH 4.5, shown to be optimal for this
reaction [29]. Procathepsin B was processed in 5 ml (0.22^1.42 WM
¢nal concentration) or 1 ml (at 3.4 and 6.5 WM) of processing bu¡er.
Aliquots of 20, 10 or 5 Wl were then withdrawn at appropriate times
and added to 2 ml substrate solution (10 WM Z-Arg-Arg-AMC con-
centration) in 0.1 M phosphate bu¡er pH 6.0, containing 1 mM
EDTA and 0.1% (w/v) polyethyleneglycol 6000 (Serva) to prevent
adsorption to the cuvette walls. Such a bu¡er was chosen as optimal
for synthetic substrate hydrolysis by cathepsin B [1], as well as to
prevent further processing of the enzyme (see Section 3). Fluorescence
of the released product was monitored continuously for 1 min in a
Perkin Elmer LS-50 spectro£uorimeter (USA) at excitation and emis-
sion wavelengths of 370 and 460 nm, respectively. The dimethylsulf-
oxide concentration was less than 3% throughout.
Fast reactions (i.e. formation and dissociation of the procathepsin
B-cathepsin B complex) were monitored by a DX 17MV stopped-£ow
apparatus (Applied Photophysics, UK) essentially as described previ-
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ously [30,31]. Brie£y, in the ¢rst experiment (complex formation), one
syringe was ¢lled with pre-warmed 50 nM cathepsin B in processing
bu¡er and the other with 500 WM Z-Arg-Arg-AMC and 10 WM pro-
cathepsin B in the processing bu¡er at pH 6.0 in order to prevent
spontaneous procathepsin B autoactivation. A 10:1 (v/v) mixing ratio
resulting in a constant ¢nal pH of 4.5 was used. In the second experi-
ment, one syringe was ¢lled with pre-warmed 50 WM Z-Arg-Arg-
AMC in the processing bu¡er and the other with pre-warmed 10
WM cathepsin B and 20 WM procathepsin B in the processing bu¡er.
The enzyme and proenzyme were mixed just prior to the measurement
(6 45 s). A 10:1 (v/v) mixing ratio was used to induce dissociation of
the complex. The release of AMC product in both experiments was
monitored at an excitation wavelength of 360 nm with a cuto¡ ¢lter
with V50% transmission at 400 nm. For control, the experiments
were repeated with cathepsin B or procathepsin B alone.
2.3. Circular dichroism (CD) measurements
Fifty Wl of procathepsin B, cathepsin B or mutant procathepsin B
(Cys-29-Ser) was diluted into 240 Wl of 0.1 M Tris-HCl bu¡er, pH 7.6,
containing 3 mM EDTA. After addition of 10 Wl 0.01 M DTT and 45
Wl of 1 M acetate bu¡er, pH 4.0, to adjust the pH to 4.3, reaction
mixtures were centrifuged in order to remove precipitated protein and
incubated at 37‡C. CD spectra were measured in an AVIV 62A DS
CD spectrometer (Lakewood, NJ, USA) immediately and after 5 h,
when autoprocessing was completed at this pH. Cells with pathlengths
of 1 cm in the near UV region (340^250 nm) and 1 mm in the far UV
region (250^210 nm) were used. Protein concentrations were 0.31 mg/
ml for mature cathepsin B and 0.29 mg/ml for Cys-29-Ser procathep-
sin B and wild-type procathepsin B, respectively, in both near and far
UV regions.
2.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE)
Procathepsin B activation was analyzed by SDS-PAGE under re-
ducing conditions on 12% gels (7U8 cm) according to Laemmli [32].
DTT (¢nal concentration 0.2 WM) was added to procathepsin B sol-
ution (57 or 7.6 WM procathepsin B in processing bu¡er). The reaction
mixture was incubated at pH 4.5 and 37‡C. Twelve Wl aliquots were
taken at di¡erent time intervals and processing was stopped by the
addition of 4 Wl of 4Usample bu¡er, containing 4% (v/v) of 2-mer-
captoethanol, followed by 5 min boiling.
2.5. Theoretical
Autocatalytic processing can be represented by Scheme 1:
where E, S and ES represent cathepsin B, procathepsin B and the
reversible complex, respectively. In Scheme 1, the Michaelis constant
is given by (k31+kcat)/k1 and the catalytic constant by kcat. Assuming
that the complex is formed under quasi-equilibrium conditions
(k31Ekcat), Km can be substituted by the equilibrium dissociation
constant, Ks, de¢ned by:
Ks  EWSES 1
In the later stages of an autocatalytic reaction, [ES] is not negligible
compared to [S] and Eq. 1 needs to be modi¢ed:
Ks  E3ESS3ESES 2
Rearranging,
ES23E  SKsES  ES  0 3
which has the following solution for [ES]:
ES E  SKs3
E  SK s234EWSp
2
4
The following conservation law is valid under equilibrium conditions
[33] :
X E ES 5
where X represents the total concentration of enzyme at any time t
during the reaction. Scheme 1 can therefore be reduced to Scheme 2:
The solution for [ES], given by Eq. 4, was introduced into the
system of di¡erential equations, describing the time course of auto-
catalytic activation of procathepsin B according to the mechanism
represented by:
dX
dt
 3kcatES  2kcatES kcatES 6
dES
dt
 3kcatES 7
dS
dt
 3kcatES 8
Unfortunately, such a system of di¡erential equations has no analyt-
ical solution. Therefore, the evaluation of kinetic parameters from
di¡erential Eqs. 6^8 was done by simultaneous ¢tting of the numeri-
cally solved system to all experimental data using a non-linear least
square analysis [34]. Since the aliquot was diluted 100^400-fold in the
substrate solution, resulting in a rapid establishment of the new equi-
librium E+S3ES, prior to measurement, the measured quantity
[E]W[X], i.e. [E]+[ES].
3. Results
3.1. Kinetics of procathepsin B autoprocessing
The kinetics of procathepsin B autoprocessing were studied
at pH 4.5 by a discontinuous method. Fig. 1 shows a sigmoi-
dal increase of cathepsin B activity showing the appearance of
newly processed cathepsin B during the reaction. All data (24
data sets) were simultaneously analyzed as described under
Section 2 (Section 2.5) and a good ¢t to the experimental
data (Fig. 1, for clarity, only six data sets are shown) indi-
cated that the proposed model (Scheme 1) satisfactorily de-
scribed the process, giving the best estimates of 2.1 þ 0.9 WM
for Ks and 0.12 þ 0.02 s31 for kcat. In agreement with the
proposed mechanism, the rate of processing was concentra-
tion-dependent with half-lives of V100 and V15 min at a
0.22 and 6.5 WM procathepsin B concentration, respectively
(Fig. 1).
To verify the bimolecularity of the process, autoactivation
of procathepsin B was followed in the presence of 10 or 20%
(v/v) glycerol. Autoprocessing of procathepsin B (0.68 WM) in
the absence of glycerol was completed in W140 min
(t1=2 = 75 þ 5 min; Fig. 1), but was V2-fold slower in the
presence of 10% glycerol (t1=2 = 160 þ 10 min) and V4-fold
slower in the presence of 20% glycerol (t1=2 = 320 þ 20 min)
(data not shown). In another experiment, a catalytic amount
of active cathepsin B (0.057 WM ¢nal concentration) was
added to procathepsin B (0.68 WM ¢nal concentration), which
substantially accelerated the processing (t1=2 = 25 þ 5 min vs.
t1=2 = 75 þ 5; data not shown).
In the analysis, we used a mixed equilibrium and steady-
state assumption, which assumes essentially instantaneous
complex formation during the entire course of the reaction.
Scheme 1.
Scheme 2.
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Kinetic data obtained under the experimental conditions used,
however, did not provide any information on the time course
of complex formation and, therefore, prevented us from treat-
ing the reaction as a non-equilibrium system. To obtain addi-
tional information on the rapid steps involved, i.e. complex
formation and dissociation, we used stopped-£ow mixing. We
tried to follow the complex formation, but the time course of
AMC formation was linear, indicating that association was
complete within the dead time of the apparatus (V2 ms),
thus justifying the initial assumption. In control experiments
performed using cathepsin B or procathepsin B alone, AMC
formation was also linear, although the slope was V20-fold
steeper in the presence of cathepsin B, indicating that during
the stopped-£ow measurement (0^60 s), no signi¢cant amount
of procathepsin B was processed. In an additional attempt, we
tried to dissociate the complex by 10-fold dilution. However,
complete processing of procathepsin B was observed in less
than 45 s under the conditions used (10 WM cathepsin B and
20 WM procathepsin B concentrations).
To con¢rm the enzyme assay studies, autoprocessing of
procathepsin B was followed by SDS-PAGE as outlined in
Section 2. At both procathepsin B concentrations (57 and
7.6 WM, not shown), processing was virtually complete within
20^25 min (Fig. 2). This time is in reasonable agreement with
the results obtained at a high procathepsin B concentration
(6.5 WM) by the enzyme assay method. Although no concen-
tration-dependence of the processing rate could have been
observed at high procathepsin B concentrations (s 5 WM)
by either of the two methods used, this can be explained by
the very high procathepsin B concentration, which was higher
than the Ks value of the process (2.1 WM).
3.2. Structural studies of procathepsin B processing
Since lowering the pH was suggested to trigger autocata-
lytic processing of procathepsin B [19], possible conformation-
al changes accompanying processing were monitored by CD
in the near and far UV region using procathepsin B, mature
cathepsin B and inactive Cys-29-Ser mutant of procathepsin
B. Near UV CD spectra were similar for all three proteins and
did not change signi¢cantly even after incubation at pH 4.3
for several hours (data not shown). Far UV CD spectra for
the three proteins were also similar at the beginning of proc-
essing. Whereas the Cys-29-Ser procathepsin B spectrum re-
mained almost the same after prolonged exposure to pH 4.3,
small changes were observed in the procathepsin B spectrum
(Fig. 3). Changes were most pronounced below 222 nm, in-
dicating a di¡erence in the K-helix content.
3.3. E¡ect of pH and dextran sulfate on the autoprocessing of
procathepsin B
Autocatalytic processing of procathepsin B was studied as a
function of pH in the absence and presence of dextran sulfate.
In a preliminary experiment, processing at pH 4.5 was moni-
tored in the presence of 5 and 20 Wg/ml dextran sulfate. Since
no di¡erence in the processing rate was observed, all subse-
Fig. 1. Time course of procathepsin B autoprocessing at pH 4.5 and 37‡C. Starting concentration of procathepsin B: (A) 0.24 WM, (B) 0.78
WM, (C) 0.47 WM, (D) 1.34 WM, (E) 3.44 WM and (F) 6.58 WM. The solid lines are the theoretical curves corresponding to the best estimates of
Ks (2.1 WM) and kcat (0.12 s31) obtained by simultaneous non-linear regression analysis as described under Section 2.5. All experimental details
are given in Section 2.
Fig. 2. SDS-PAGE analysis of procathepsin B activation at pH 4.5
and 37‡C. Procathepsin B (57 WM) was incubated in the processing
bu¡er from 0 to 70 min as described in Section 2. Low Mr stand-
ards are shown in lane 1 (St).
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quent experiments were performed in the presence of 5 Wg/ml
dextran sulfate, a concentration similar to those used in stud-
ies of procathepsin L [28] and factor XII [35] activation. In
the absence of dextran sulfate, processing was the fastest at
pH 4.5 (Table 1) and the rate decreased towards lower or
higher pH, in agreement with previous results [15]. In the
presence of dextran sulfate, processing was substantially faster
(15^40-fold, Table 1). Furthermore, a reasonably rapid proc-
essing was observed even at pH 6.5, in contrast to the results
in the absence of dextran sulfate where no processing was
observed above pH 6.0.
4. Discussion
The results show that autoactivation of procathepsin B is a
bimolecular process. The sigmoidal increase of cathepsin B
activity with time (Fig. 1) indicated that processing is an in-
termolecular rather than an intramolecular process. In the
latter case, an exponential increase of activity with time would
have been observed. Furthermore, the rate of processing was
concentration-dependent (Fig. 1) and not independent, as
would be expected for an intramolecular process. Additional
evidence for the bimolecularity of autoprocessing was pro-
vided by the experiments in the presence of glycerol, which
is known to slow down di¡usion of the molecules in solution
by increasing the solution viscosity. In the presence of 20%
(v/v) glycerol, a V4-fold deceleration of autoprocessing was
observed, whereas in the case of an intramolecular (unimolec-
ular) process, glycerol should not have a¡ected the processing
rate. Moreover, addition of a small amount of mature active
cathepsin B accelerated the process V3-fold, indicating that
mature cathepsin B is the catalytic species in the process.
Finally, the only apparent deviation from the bimolecularity,
virtual concentration-independence of the processing rate at a
high procathepsin B concentration, could well be explained by
the saturation conditions, i.e. [So]EKm.
An important question concerns the origin of the initial
cleavage reaction. Based on the crystal structure of procathep-
sin B [19], it was suggested that an early conformational
change in the propeptide induced by the pH drop may trigger
processing of the proteinases. This was supported by another
study, where pH-induced conformational changes were ob-
served on the propeptide of cathepsin L [36]. However,
when autoactivation of cathepsin L was studied, no confor-
mational changes were observed during processing [17], in
contrast with the above suggestion. In agreement with the
latter study, we observed no conformational change when
Cys-29-Ser procathepsin B was exposed to pH 4.3 for as
long as 5 h (Fig. 3), which is considerably longer than the
time needed for complete processing of the enzyme. Also ma-
ture cathepsin B proved to be completely stable and active
during this period (Fig. 3, J. Rozman, unpublished results).
However, conformational changes in the K-helices were ob-
served by the same treatment of procathepsin B (Fig. 3).
Moreover, after 5 h, the far UV CD spectra of procathepsin
B and mature cathepsin B were similar, consistent with pro-
cathepsin B being completely processed. This further suggests
that propeptide, which is mainly K-helical [18,19], was un-
folded after the cleavage, explaining also the results of Jerala
et al. [36].
Although a major conformational change in the propeptide,
triggered by the pH drop, is not the initial step in the activa-
tion of papain-like proteinases, interactions between propep-
tide and the catalytic part are substantially weaker after the
pH change, as judged on the basis of interaction between
Fig. 3. Far UV CD spectra of mature cathepsin B (A), Cys-29-Ser
procathepsin B (B) and procathepsin B (C) at pH 4.3 and 37‡C.
Solid lines correspond to t = 1 min after mixing and dashed lines to
t = 5 h. Protein concentrations were 0.31 mg/ml in A, 0.29 mg/ml in
B and 0.29 mg/ml in C. Other experimental details are given in Sec-
tion 2.
Table 1
E¡ect of pH and dextran sulfate on the rate of procathepsin B
processing at 37‡C
pH 3DS t1=2 (min) +DS t1=2 (min)
4.0 140 þ 10 n.d.
4.5 75 þ 5 5 þ 1
4.9 130 þ 10 7 þ 1
5.1 160 þ 10 n.d.
5.8 800 þ 50 18 þ 2
6.25 n.d. 25 þ 2
6.55 n.d. 90 þ 5
Estimates of procathepsin B processing half-times in the absence
(3DS) and in the presence (+DS) of 5 Wg/ml dextran sulfate, ob-
tained by the discontinuous method, are given together with their
S.E.M.s. The procathepsin B concentration was 0.68 WM in all ex-
periments. Other experimental details were as described in Section
2. n.d. is not determined.
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cathepsin B and the propeptide [10]. As a consequence, pro-
enzyme probably adopts a looser conformation, in which pro-
peptide is bound less tightly into the active site without loss of
the secondary structure. Initiation of the chain reaction of
peptide cleavage, however, remains an intriguing part of the
whole process. Although we and others [16,37,38] have ob-
served that proenzymes exhibit a very small catalytic activity,
which may be su⁄cient to initiate the chain reaction, presence
of catalytic amounts of other proteinases, either from tissue or
resulting from various expression systems, cannot be totally
excluded. In the next step, processing is rapidly accomplished
by the increasing number of catalytically active enzyme mol-
ecules. Such a transactivation was observed for both cathepsin
B (see Section 3) and also cathepsin K [16]. Cleaved propep-
tides were suggested to delay the ¢nal processing step by in-
hibiting mature proteinases [10,15,39]. However, quantitative
processing over the whole concentration range, which was
considerably faster at higher procathepsin B concentrations
(Fig. 1), was observed, suggesting that such a mechanism is
not very likely. It is more likely that the propeptide, after
serving its role to prevent inappropriate protease activity
and being cleaved, dissociates from the protease. This is fol-
lowed by unfolding and degradation of the propeptide by
proteases. The major pH-induced conformational changes of
cathepsin S propeptide and its rapid cleavage by cathepsin L
below pH 5.5 are in line with our suggestion [40]. Alterna-
tively, propeptide can be cleaved at several sites already dur-
ing activation, thus eliminating or diminishing its inhibitory
function, as observed for propeptides of cathepsins L and K
[16,17].
Procathepsin B autoactivation in the presence of dextran
sulfate was shown to be substantially accelerated (15^40-
fold) and signi¢cant up to pH 6.5, whereas in the absence
of dextran sulfate, it is very slow at pHs 5.5. Although no
major acceleration of procathepsin B activation was observed
in the presence of heparin or chondroitin sulfate [15], rapid
processing of procathepsin L was observed in the presence of
dextran sulfate [28] and other glycosaminoglycans [41]. Dex-
tran sulfate and related glycosaminoglycans can thus substan-
tially accelerate in vitro autoactivation of lysosomal cysteine
proteases by weakening the interaction between propeptide
and the catalytic part. Since glycosaminoglycans can be found
in lysosomes as a result of proteoglycan recycling, it is possi-
ble that they are also involved in in vivo processing of cysteine
proteinases, although there is no experimental evidence yet.
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